Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for December 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Fetal Antiretroviral Exposure Impacts Cardiac Development
THURSDAY, Dec. 23 (HealthDay News) -- Fetal exposure to antiretroviral therapy (ART) appears to be associated with increased left ventricular (LV) fractional shortening and contractility as well as reduced LV mass, septal thickness, and LV dimension, especially in girls, according to a study published in the Jan. 4 issue of the Journal of the American College of Cardiology.
Abstract
Full Text (subscription or payment may be required)
Expanded Screening, Treatment Could Reduce New HIV Infections
THURSDAY, Dec. 23 (HealthDay News) -- Expanding screening and treatment for HIV would likely reduce the rate of new infections, especially if combined with interventions that result in less risky behavior, according to research published in the Dec. 21 issue of the Annals of Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
New Drug Shows Promise in Fighting HIV
THURSDAY, Dec. 23 (HealthDay News) -- A new drug based on a compound produced by the human body appears to block fusion peptides and halt an early stage of HIV infection by thwarting interaction between the virus and host cells, according to research published in the Dec. 22 issue of Science Translational Medicine.
Abstract
Full Text (subscription or payment may be required)
Once-Daily Dose Approved for Prezista
TUESDAY, Dec. 14 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new once-daily dose for Prezista (darunavir), combined with ritonavir to treat people infected with HIV-1.
New Technologies Allow for Better Tracking of HIV
THURSDAY, Dec. 2 (HealthDay News) -- A review published online Dec. 1 in The Lancet Infectious Diseases discusses the emergence and tracking of new strains of HIV as well as the methodological progress made in tracking the global molecular evolution of the virus, including its many circulating recombinant forms (CRFs).
Abstract
Full Text (subscription or payment may be required)
Burnout Driving Away Many Emergency Physicians
THURSDAY, Dec. 2 (HealthDay News) -- Conflicts between work and family and poor on-the-job teamwork contribute to burnout and drive many physicians, particularly emergency physicians, to want to leave their profession, according to a study published online Dec. 1 in the Emergency Medicine Journal.
Abstract
Full Text (subscription or payment may be required)
CDC: HIV Testing Among Adults Increasing
WEDNESDAY, Dec. 1 (HealthDay News) -- The number of adults ever tested for HIV is increasing, though nearly one-third of diagnoses still occur during late stages of disease, according to a report published in the Nov. 30 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Copyright © 2011 ScoutNews, LLC. All rights reserved.
| Previous: December 2010 Briefing - Gastroenterology | Next: December 2010 Briefing - Infectious Disease |
|
Reader comments on this article are listed below. Review our comments policy. |
Submit your opinion:
 |
||
|
|
Are you a Doctor, Pharmacist, PA or a Nurse?Join the Doctors Lounge online medical community
|
|
